Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of a targeted hepatitis B vaccination program in Amsterdam, The Netherlands.

Vaccine - 30 Mar 2007

van Houdt Robin, Sonder Gerard J B, Dukers Nicole H T M, Bovee Lian P M J, van den Hoek Anneke, Coutinho Roel A, Bruisten Sylvia M

Abstract excerpt

To evaluate hepatitis B virus (HBV) risk group vaccination in Amsterdam, which started in 1998, we examined 342 reported acute HBV-cases and sequenced 85 DNA isolates. The reported number of cases declined from 214 in 1992-1997 to 128 in 1998-2003, due to a decline in injecting drug users (IDU) and their heterosexual partners. Phylogenetic analyses showed that after 1998, the IDU cluster nearly disappeared,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis B
Share to Hepatitis B Vaccines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B virus

Share to Homosexuality, Male

Share to Netherlands

Share to Phylogeny

Share to Substance Abuse, Intravenous

Share to Vaccination

Source

Identifiers

PMID: 16919856
DOI: 10.1016/j.vaccine.2006.06.058

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of a targeted hepatitis B vaccination program in Amsterdam, The Netherlands.PMID 16919856Read ↗

Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: does it work?Semantic proximity Read ↗

Selective hepatitis B virus vaccination has reduced hepatitis B virus transmission in the Netherlands.Semantic proximity Read ↗

Molecular sequence data of hepatitis B virus and genetic diversity after vaccination.Semantic proximity Read ↗

Two decades of hepatitis B infections among drug users in Amsterdam: are they still a high-risk group?Semantic proximity Read ↗

Two years' prospective collection of molecular and epidemiological data shows limited spread of hepatitis A virus outside risk groups in Amsterdam, 2000-2002.Semantic proximity Read ↗

Ongoing transmission of a single hepatitis B virus strain among men having sex with men in Amsterdam.Semantic proximity Read ↗

Molecular epidemiology of acute hepatitis B in the Netherlands in 2004: nationwide survey.Semantic proximity Read ↗

Widespread hepatitis B virus genotype G (HBV-G) infection during the early years of the HIV epidemic in the Netherlands among men who have sex with men.Semantic proximity Read ↗

High prevalence of hepatitis B virus dual infection with genotypes A and G in HIV-1 infected men in Amsterdam, the Netherlands, during 2000-2011.Semantic proximity Read ↗

MSM starting preexposure prophylaxis are at risk of hepatitis C virus infection.Semantic proximity Read ↗

Minimization of hepatitis B infection by a 25-year universal vaccination program.Semantic proximity Read ↗

Changing serological status and low vaccination-induced protection rates against hepatitis B characterize chronic hepatitis C virus-infected injecting drug users in Greece: need for immunization policy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.